Gradient Investments LLC - ACTINIUM PHARMACEUTICALS INC ownership

ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 42 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.

Quarter-by-quarter ownership
Gradient Investments LLC ownership history of ACTINIUM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$391
-20.2%
660.0%0.00%
Q2 2023$490
-21.5%
660.0%0.00%
Q1 2023$624
-11.2%
660.0%0.00%
Q4 2022$703660.0%0.00%
Q3 2022$0660.0%0.00%
Q2 2022$0660.0%0.00%
Q1 2022$0660.0%0.00%
Q4 2021$0
-100.0%
660.0%0.00%
Q3 2021$1,0000.0%660.0%0.00%
Q2 2021$1,0000.0%660.0%0.00%
Q1 2021$1,0000.0%660.0%0.00%
Q4 2020$1,0000.0%660.0%0.00%
Q3 2020$1,000660.00%
Other shareholders
ACTINIUM PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Interchange Capital Partners, LLC 16,420$145,0000.24%
ACT CAPITAL MANAGEMENT, LLC 37,500$332,0000.17%
GSA CAPITAL PARTNERS LLP 68,205$604,0000.06%
GOODWIN DANIEL L 10,000$88,0000.04%
SABBY MANAGEMENT, LLC 26,488$235,0000.03%
EMFO, LLC 1,666$15,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 79,166$701,0000.01%
Retirement Group, LLC 1,129$15,0000.01%
Wealthspire Advisors, LLC 14,348$127,0000.00%
BLAIR WILLIAM & CO/IL 82,366$730,0000.00%
View complete list of ACTINIUM PHARMACEUTICALS INC shareholders